Tags

Type your tag names separated by a space and hit enter

Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats.
BMC Pharmacol 2008; 8:4BP

Abstract

BACKGROUND

Seaweeds or marine algae have long been made up a key part of the Asian diet, and as an antioxidant, sulphated polysaccharides have piqued the interest of many researchers as one of the ocean's greatest treasures. The present investigation suggests the therapeutic potential of sulphated polysaccharides from marine brown algae "Sargassum wightii" in Cyclosporine A (CsA)- induced liver injury. CsA is a potent immunosuppressive agent used in the field of organ transplantations and various autoimmune disorders. However, hepatotoxicity due to CsA remains to be one of the major clinical challenges.

METHODS

The effect of sulphated polysaccharides on CsA-induced hepatotoxicity was studied in adult male albino rats of Wistar strain, and the animals were randomized into four groups with six rats in each. Group I served as vehicle control. Group II rats were given CsA at a dosage of 25 mg/kg body weight, orally for 21 days. Group III rats were given sulphated polysaccharides at a dosage of 5 mg/kg body weight, subcutaneously for 21 days. Group IV rats were given sulphated polysaccharides simultaneously along with CsA, as mentioned in Group II for 21 days.

RESULTS

CsA provoked hepatotoxicity was evident from the decreased activities of hepatic marker enzymes. A significant rise in the level of oxidants, along with a striking decline in both the enzymic and non-enzymic antioxidants, marks the severity of oxidative stress in CsA-induced rats. This in turn led to enhanced levels of lipid peroxidation, 8-hydroxy-2-deoxy guanosine and protein carbonyls, along with a decrease in ATPase activities and alterations in lipid profile. Histopathological changes also strongly support the above aberrations. However, concomitant treatment with sulphated polysaccharides restored the above deformities to near control and prevented the morphological alterations significantly.

CONCLUSION

Thus, the present study highlights that sulphated polysaccharides can act therapeutically against CsA-induced hepatotoxicity.

Authors+Show Affiliations

Department of Medical Biochemistry, Dr, ALM, Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai - 600 113, India. ajose_joy@yahoo.co.in

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18289374

Citation

Josephine, Anthony, et al. "Role of Sulphated Polysaccharides From Sargassum Wightii in Cyclosporine A-induced Oxidative Liver Injury in Rats." BMC Pharmacology, vol. 8, 2008, p. 4.
Josephine A, Nithya K, Amudha G, et al. Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats. BMC Pharmacol. 2008;8:4.
Josephine, A., Nithya, K., Amudha, G., Veena, C. K., Preetha, S. P., & Varalakshmi, P. (2008). Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats. BMC Pharmacology, 8, p. 4. doi:10.1186/1471-2210-8-4.
Josephine A, et al. Role of Sulphated Polysaccharides From Sargassum Wightii in Cyclosporine A-induced Oxidative Liver Injury in Rats. BMC Pharmacol. 2008 Feb 20;8:4. PubMed PMID: 18289374.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats. AU - Josephine,Anthony, AU - Nithya,Kalaiselvam, AU - Amudha,Ganapathy, AU - Veena,Coothan Kandaswamy, AU - Preetha,Sreenivasan P, AU - Varalakshmi,Palaninathan, Y1 - 2008/02/20/ PY - 2007/11/29/received PY - 2008/02/20/accepted PY - 2008/2/22/pubmed PY - 2008/4/18/medline PY - 2008/2/22/entrez SP - 4 EP - 4 JF - BMC pharmacology JO - BMC Pharmacol. VL - 8 N2 - BACKGROUND: Seaweeds or marine algae have long been made up a key part of the Asian diet, and as an antioxidant, sulphated polysaccharides have piqued the interest of many researchers as one of the ocean's greatest treasures. The present investigation suggests the therapeutic potential of sulphated polysaccharides from marine brown algae "Sargassum wightii" in Cyclosporine A (CsA)- induced liver injury. CsA is a potent immunosuppressive agent used in the field of organ transplantations and various autoimmune disorders. However, hepatotoxicity due to CsA remains to be one of the major clinical challenges. METHODS: The effect of sulphated polysaccharides on CsA-induced hepatotoxicity was studied in adult male albino rats of Wistar strain, and the animals were randomized into four groups with six rats in each. Group I served as vehicle control. Group II rats were given CsA at a dosage of 25 mg/kg body weight, orally for 21 days. Group III rats were given sulphated polysaccharides at a dosage of 5 mg/kg body weight, subcutaneously for 21 days. Group IV rats were given sulphated polysaccharides simultaneously along with CsA, as mentioned in Group II for 21 days. RESULTS: CsA provoked hepatotoxicity was evident from the decreased activities of hepatic marker enzymes. A significant rise in the level of oxidants, along with a striking decline in both the enzymic and non-enzymic antioxidants, marks the severity of oxidative stress in CsA-induced rats. This in turn led to enhanced levels of lipid peroxidation, 8-hydroxy-2-deoxy guanosine and protein carbonyls, along with a decrease in ATPase activities and alterations in lipid profile. Histopathological changes also strongly support the above aberrations. However, concomitant treatment with sulphated polysaccharides restored the above deformities to near control and prevented the morphological alterations significantly. CONCLUSION: Thus, the present study highlights that sulphated polysaccharides can act therapeutically against CsA-induced hepatotoxicity. SN - 1471-2210 UR - https://www.unboundmedicine.com/medline/citation/18289374/Role_of_sulphated_polysaccharides_from_Sargassum_Wightii_in_Cyclosporine_A_induced_oxidative_liver_injury_in_rats_ L2 - https://bmcpharma.biomedcentral.com/articles/10.1186/1471-2210-8-4 DB - PRIME DP - Unbound Medicine ER -